News Medical on MSN3d
Asthma and antibiotic use may predict nasal polyp recurrence after endoscopic sinus surgery: Study
The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on ...
Too Old to Operate3d
Bilateral CRSwNP Linked to Unique Risks Versus Unilateral Cases
Bilateral versus unilateral cases of chronic rhinosinusitis with nasal polyps have notable clinical and laboratory ...
Asthma and antibiotic use may predict nasal polyp recurrence after endoscopic sinus surgery
The probability of revision sinus surgery including removing nasal polyps is higher if the patient has asthma or is on ...
Science Daily9d
Asthma and antibiotic use may predict nasal polyp recurrence after endoscopic sinus surgery
Nasal polyps are benign mucosal protrusions that can, in severe cases, block the nostrils entirely. Nasal polyps often develop in conjunction with a prolonged sinus infection, leading to chronic ...
GSK's depemokimab gets EMA nod for asthma and nasal polyps
GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.29 billion and currently ...
HealthDay on MSN6d
Baseline Characteristics ID Risk for Recurrent Endoscopic Sinus Surgery
THURSDAY, Feb. 6, 2025 (HealthDay News) -- A few baseline characteristics can predict the need for recurrent endoscopic sinus ...
pharmaphorum2d
FDA says no to AZ's Fasenra for nasal polyp indication
AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...
News Medical27d
Granzyme K+ CD8+ T-cells identified as key drivers of recurrent airway inflammation
Study uncovers a pathogenic subset of memory T-cells that promote tissue inflammation and highlights a potential target for treating nasal polyps and other inflammatory airway diseases.